Brain Injury Enrolling by Invitation Phase 2 Trials for Tolcapone (DB00323)

Also known as: Brain Injuries / Brain Damage / Head injury NOS / Cerebral damage / Brain injury NOS

IndicationStatusPhase
DBCOND0028243 (Brain Injury)Enrolling by Invitation2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02652598Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCDTreatment